Published in ACS Applied Materials & Interfaces Researchers report Gas6-engineered neural stem cell membrane–coated nanoparticles...

Published by Harvard Medical School This HMS explainer walks through modern immunotherapy, from checkpoint inhibitors that release immune...

Published on Cytotherapy via LinkedIn Cytotherapy’s new podcast features CAR-T pioneer Bruce Levine in conversation with Patrick Hanley....

Published on LinkedIn via Spencer Knight The FDA has given accelerated approval to Jazz Pharmaceuticals’ Modeyso (dordaviprone) for...

Published by UMC Utrecht In the PASSIoN safety study at UMC Utrecht, ten newborns with perinatal stroke received a single dose of...

Published in The Japan Times Sumitomo Pharma has applied for regulatory approval in Japan to market a cell therapy that transplants...

Published on ISCT Telegraft Blog by Francheska Juliano At the ISCT 2024 Annual Meeting in Vancouver, global experts discussed how access...

Published in Regenerative Therapy (Vol. 30, Dec 2025) A study in Regenerative Therapy shows that adipose-derived stem cells (ADSCs)...

Published on LinkedIn via Spencer Knight Jan Janisch-Hanzlik, 49, became the first person in the world to receive allogeneic CAR‑T...

Published by University of Tokyo via Nature Communications Researchers at the University of Tokyo have developed a novel system that...

Published on Drug Discovery News Recent FDA rejections of three advanced therapies, Capricor’s CAP‑1002, Ultragenyx’s DTX401, and Rocket...

Published on LinkedIn via Spencer Knight SERB Pharmaceuticals will acquire Y-mAbs Therapeutics for $412 million, marking a strategic...

Published on OncoDaily via Hung Trinh In a first‑in‑human trial led by UCLA, researchers demonstrated that hematopoietic stem cells...

Published by Cytotherapy via LinkedIn A new paper describes a fully integrated platform that automates three core CAR‑T manufacturing...

Published on LinkedIn via Spencer Knight In a groundbreaking study by Karolinska Institutet, ten patients born deaf due to a mutation in...

Published on LinkedIn via Spencer Knight The FDA has granted two approvals within 24 hours. Novartis’s Leqvio (inclisiran), a...

Published in Alliance for Regenerative Medicine (April 2025 Preview) A new whitepaper from the Alliance for Regenerative Medicine...

Published on Mass General Brigham After years of debilitating pain from sickle cell disease, Allan Byamukama became one of the first...

Published on LinkedIn via Spencer Knight AbbVie has secured worldwide rights to ISB 2001, a first-in-class trispecific antibody developed...

Published on LinkedIn via Spencer Knight GSK has entered a $12 billion licensing deal with China’s Hengrui Pharma, paying $500 million...